Validating Complex Biomarker Panels & Innovative Diagnostic Platforms Across Europe For Scalable Precision Medicine Approvals, Adoption & Market Access
With IVDR performance study guidance now in force, German reimbursement reforms underway, and NHS England advancing liquid biopsy rollouts, Europe is entering a new era of precision medicine. As novel and digital diagnostics accelerate, the question is no longer whether they enable fit-for-purpose biomarker strategies, but how quickly clinical, regulatory, and commercial systems can keep pace.
Amid this momentum, the 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the region’s longest-standing precision medicine forum, bringing together 300+ senior leaders across biopharma, diagnostics, regulation, reimbursement, and healthcare to define biomarker strategies and ensure day-one drug-diagnostic market readiness.
Featuring brand-new case studies from 60+ expert speakers, this meeting is the definitive European platform for knowledge exchange and collaboration, removing barriers to faster, more equitable precision healthcare across oncology, neurological, autoimmune, and chronic diseases.
Insightful conversations and presentations across the spectrum of biomarkers and CDx development. Realising that the whole community faces similar challenges, this forum offers a discussing-pot for viable solutions.
Past Attendee, Boehringer Ingelheim
This meeting provides an opportunity to connect with existing and potential future Dx partners and exchange ways to manage hurdles in co-development with other Pharma, CROs and Notified Bodies.
Past Attendee, Daiichi Sankyo
The sessions were expertly curated and the audience was engaged, offering access to high level experts across precision medicine industry and academia. Really appreciated being part of this event!
Past Attendee, Genomics England
Download Full Event Guide
- Free* to Attend for Biopharma & Academia
- Europe’s Leading Biomarker & Companion Diagnostic Forum
- Solid Tumour & Liquid Biopsy Biomarker Strategies
- Oncology, Neurological & Infectious Disease Case Studies
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Gain first-hand insights into the latest translational, clinical and commercial strides shaping biomarker-led trials and CDx approvals. From IVDR, to the COMBINE pilot, explore Europe’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive Rx-Dx partnership discussions
Partner With Us
Position your brand alongside leading global and European-local IVD innovators, clinical and biosample management leaders and laboratory service to stay of the pinnacle of bringing precision therapeutics from bench-to-bedside
Join Biopharma Experts
Join Europe’s most comprehensive and trusted senior precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas, modalities, biosample types and testing platforms